American tegumentary leishmaniasis (ATL) is considered a neglected disease, for which an e ff ective vaccine or an e ffi cient diagnosis is not yet available and whose chemotherapeutic arsenal is threatened by the emergence of resistance by etiological agents such as Leishmania amazonensis . ATL is endemic in poor countries and has a high incidence in Brazil. Vaccines developed from native parasite fractions ha...